UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Securities~~Date ~~Exchange~~of ~~Act~~Report (Date of ~~1934~~earliest event reported): February 13, 2018

~~Date~~MEDPRO ofSAFETY ~~report~~PRODUCTS, INC. (~~Date~~Exact name of ~~earliest~~registrant ~~event~~as ~~reported~~specified in its charter):

December 12, 2013

Nevada	000-52077	91-2015980
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)

MEDPRO SAFETY PRODUCTS, INC.

20311 Chartwell Center Drive, Suite 1469

Cornelius, NC

28031

(Address of principal executive offices)

(Zip Code)

(~~Exact Name of Registrant as Specified in its Charter~~704) 790-9799

Nevada		000-52077		91-2015980
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employee Identification No.)

(Issuer's telephone/facsimile numbers, including area code)

145 Rose Street

Lexington, KY 40507

(~~Address~~former ofname ~~Principal~~or ~~Executive~~former ~~Offices) (Zip~~address, ~~Code~~if changed since last report)

~~(859)~~Check ~~225~~the appropriate box below if the Form 8-~~5375~~K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See: General Instruction A.2. below):

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (~~17 CFR 240~~17CFR240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (~~17 CFR 240~~17CFR240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (~~17 CFR 240~~17CFR240.13e-4(c))

~~Item~~Section ~~1.01~~5 ~~Entry~~- ~~Into~~Corporate aGovernance ~~Material~~and ~~Definitive~~Management ~~Agreement.~~

OnItem ~~December 24, 2013, MedPro Safety Products, Inc~~5.01 ~~(“MedPro” or~~Changes the “Company”) and its principal shareholder Vision Opportunity Master Fund, Ltd. (“VOMF”) entered into an amendment to MedPro’s Series D Senior Secured Promissory Note (the “Series D Note”). The amendment extends the maturity date of the Series D Note from December 31, 2013 to March 31, 2014 and increases the interest rate on the outstanding principal balance of the Series D Note from 10% to 15% during the extension period. All other terms and conditions of the Series D Note remain unmodified and in ~~full~~Control ~~force and effect. In addition, MedPro granted VOMF the right to appoint one member to MedPro’s board~~ of ~~directors any time there remains outstanding principal on the Series D Note~~Registrant.

~~The~~On ~~outstanding~~February ~~principal~~13, ~~balance~~2018, ofthe Fayette County, Kentucky, Circuit Court entered a consent judgment against the ~~Series~~Registrant, Dby ~~Note~~and isthrough ~~currently $4~~its court-appointed custodian,~~310~~ in which Plaintiffs,~~000~~ William R. ~~The~~Alessi, ~~terms~~Jr. and ~~conditions~~Pure ofEnergy ~~the~~714, ~~Series~~LLC, Dexchanged ~~Note~~their ~~are~~claims ~~described~~against the Registrant in ~~MedPro~~exchange for the issuance of nine million (9,000,000) and forty-five million (45,000,000) shares, respectively, of the Registrant’s ~~Current~~common ~~Report~~stock. onUpon ~~Form~~the ~~8-K~~Plaintiffs’ ~~filed~~information ~~September 18~~and belief, ~~2012~~the issuance represents a change of control of the Registrant as the last reported total number of common and preferred shares issued by the Registrant and outstanding was 34,540,478 common, 6,668,229 Series A preferred, 126,415 Series D preferred, and 20,000 Series E Preferred.

~~Item~~The 5Registrant’s Form 10-Q for the period ending September 30, 2013 reports that each Series D and Series E preferred share is convertible into 16.0267 ~~Departure~~common shares. On a fully converted basis, the Series D and E preferred shares convert into a total of ~~Directors~~2,440,738 orcommon ~~Certain~~shares. ~~Officers;~~Therefore, ~~Election~~at the time of ~~Directors;~~the ~~Appointment~~change of ~~Certain~~control, ~~Officers;~~there ~~Compensatory~~were ~~Arrangements~~the equivalent of ~~Certain~~a ~~Officers~~total of 43,649,445 voting common shares outstanding. With the court-approved settlement of claims and issuance of shares to Plaintiffs, the total number of equivalent voting shares issued and outstanding is 97,649,445 shares of which the Plaintiffs’ combined control is 55.3%.

OnPlaintiffs, ~~December~~Pure 23Energy 714, ~~2013~~LLC, ~~Marc~~by Tand through its sole member Louis Sorrentino, and William R. ~~Ray~~Alessi, ~~resigned~~Jr., ~~from~~individually, ~~his~~have ~~position as~~an ~~MedPro’s~~oral ~~Chief~~agreement ~~Financial~~to ~~Officer~~vote their shares together and ~~Vice~~to ~~President~~appoint ofMr. ~~Finance,~~Alessi ~~effective~~as ~~immediately~~a director and officer of the Registrant. ~~The~~ ~~Company~~Pure ~~has~~Energy ~~not~~714, ~~designated a~~LLC, ~~successor~~is atowned ~~this~~and ~~time~~controlled by Louis Sorrentino.

OnMr. ~~December~~Alessi, 12age 46, ~~2013~~is the current CEO of Lone Star Gold, ~~Andrew~~Inc. Psince February 12, 2018. ~~Merkatz~~He ~~resigned~~was asformerly athe ~~director~~ interim CEO of ~~the~~RMD ~~Company~~Entertainment Group, Inc. Mrfrom ~~Merkatz~~April ~~had~~of ~~served~~2017 asthrough October of 2017, and was the ~~designated~~interim ~~representative~~CEO of ~~VOMF~~Land onStar, ~~MedPro’s~~Inc. ~~board~~from April of ~~directors~~2017 ~~since~~to ~~March 18,~~December ~~2013~~of 2017.

~~Item 9.01. Financial Statement and Exhibits.~~2

~~(d) Exhibits.~~SIGNATURES

Exhibit No.		Description of Exhibit
10.1		Amendment dated December 24, 2013 to Series D Senior Secured Promissory Note dated September 12, 2012

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDPRO SAFETY PRODUCTS, INC.

Dated: March 2, 2018	By:	/s/ William R. Alessi, Jr.
		William R. Alessi, Jr.
	Its:	President and Chief Financial Officer

~~SIGNATURES~~3

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDPRO SAFETY PRODUCTS, INC.
Dated: December 30, 2013	By:	/s/ W. Craig Turner
		W. Craig Turner
		Chairman and Chief Executive Officer

Filing Compare · MedPro Safety Products, Inc.